VCAM-1 predicts poor prognosis and modulates immune infiltration in gastric cancer: a TCGA-based bioinformatics study
<i>VCAM-1</i> is a novel prognostic biomarker driving immunosuppressive microenvironmental remodeling in GC. Furthermore, its dual roles in immune regulation highlight its potential to optimize GC immunotherapy.
Authors
- Chuanfa Fang (ORCID: https://orcid.org/0000-0002-4950-1290)
- Y. Liu (ORCID: https://orcid.org/0000-0001-5968-3932)
- Chuanyuan Liu
- Cheng Wu (ORCID: https://orcid.org/0000-0001-7996-0335)
Institutions
- Nanchang University (CN)
- Ganzhou People's Hospital (CN)
- Nanfang Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Frontiers in Genetics
- Published
- 2025-08-25
- DOI
- https://doi.org/10.3389/fgene.2025.1602929
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Health Commission of Jiangxi Province